Evidence map›Paper›PMID 42901991›Full record

ArticleNature medicine2026

Author Correction: FcRH5×CD3 bispecific antibody cevostamab in relapsed or refractory multiple myeloma: a phase 1 trial.

Adam D Cohen, Joshua Richter, Suzanne Trudel, Alexander Lesokhin, Jacob P Laubach, Sheeba K Thomas, Simon J Harrison, Luciano J Costa, Andrew Spencer, Rafael Fonseca and 14 more

Abstract readPublished Erratum
PubMed Publisher
In one paragraph

Article in Nature medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

24 authors.

Adam D Cohen *Abramson Cancer Center and University of Pennsylvania, Philadelphia, PA, USA. adam.cohen@pennmedicine.upenn.edu.ORCID http://orcid.org/0000-0003-0939-3843
Joshua Richter *Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Suzanne Trudel *Princess Margaret Cancer Centre and University of Toronto, Toronto, Ontario, Canada.ORCID http://orcid.org/0000-0001-7952-6352
Alexander Lesokhin *Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY, USA.ORCID http://orcid.org/0000-0001-9321-702X
Jacob P LaubachDana-Farber Cancer Institute, Boston, MA, USA.
Sheeba K ThomasThe University of Texas MD Anderson Cancer Center, Houston, TX, USA.ORCID http://orcid.org/0000-0001-8596-7058
Simon J HarrisonPeter MacCallum Cancer Centre, Sir Peter MacCallum Department of Oncology, Melbourne University, and The Royal Melbourne Hospital, Melbourne, Victoria, Australia.ORCID http://orcid.org/0000-0003-4555-6582
Luciano J CostaO'Neal Comprehensive Cancer Center, University of Alabama at Birmingham, Birmingham, AL, USA.ORCID http://orcid.org/0000-0001-5362-2469
Andrew SpencerAlfred Health-Monash University, Melbourne, Victoria, Australia.
Rafael FonsecaMayo Clinic in Arizona, Phoenix, AZ, USA.ORCID http://orcid.org/0000-0002-5938-3769
Peter A ForsbergUniversity of Colorado School of Medicine, Aurora, CO, USA.
Jesus G BerdejaTennessee Oncology and Sarah Cannon Research Institute, Nashville, TN, USA.ORCID http://orcid.org/0000-0003-4362-0376
Rayan KaedbeyJewish General Hospital, McGill University, Montreal, Quebec, Canada.
Nizar J BahlisArnie Charbonneau Cancer Institute, University of Calgary, Calgary, Alberta, Canada.ORCID http://orcid.org/0000-0001-7353-7034
Paula Rodriguez-OteroClínica Universidad de Navarra, Pamplona, Spain.
Maria-Victoria MateosHospital Universitario de Salamanca, Instituto de Investigación Biomédica de Salamanca (IBSAL), Centro de Investigación del Cáncer (CIC) and Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Salamanca, Spain.ORCID http://orcid.org/0000-0003-2390-1218
Tulika TyagiGenentech, Inc., South San Francisco, CA, USA.
Divya SamineniGenentech, Inc., South San Francisco, CA, USA.
Wenyu LiuGenentech, Inc., South San Francisco, CA, USA.
Rin NakamuraGenentech, Inc., South San Francisco, CA, USA.
Voleak ChoeurngGenentech, Inc., South San Francisco, CA, USA.
Chihunt WongGenentech, Inc., South San Francisco, CA, USA.
James CooperGenentech, Inc., South San Francisco, CA, USA.
Amrita KrishnanCity of Hope Duarte, Duarte, CA, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID42901991

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.